NCT Number: NCT05526248
Phase: Phase 2
Trial Summary: Researchers are looking for a better way to treat men who have biochemically recurrent hormone-naive – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Bayer
Acronym: ARAMON
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives